Since 2012, Virbac has maintained a presence in China through a commercial subsidiary that now has about thirty collaborators. How is the subsidiary adapting to this ever-changing market? Answers by the subsidiary general manager.
On March 8, 2016, Virbac US announced the launch of the latest advancement in canine joint health supplementation, MOVOFLEX™ Soft Chews. Formulated with a unique and proprietary blend of ingredients, MOVOFLEX™ Soft Chews provide comprehensive canine joint support in a once-a-day palatable soft chew.
Virbac announces the appointment of Marie-Paule Porte as Group general counsel. Member of the strategic committee and the Comex France, in charge of legal matters at a global level, she provides support to the executive board and area directors in relation to strategic decisions they take.
A company that has always been dedicated to animal health
Founded in 1968 by a French veterinarian, Virbac is an independent pharmaceutical laboratory present in more than 100 countries. The company offers a comprehensive and practical range of products and services covering the majority of species and pathologies.
Customer driven innovation
Financial public releases
Sales grow by 3.2% at the end of September at constant rates
Growth of half-year results
Sales growth by 3.6% at constant exchange rates in the first half